Wouter Joustra

Mr. Wouter Joustra is an Independent Director at Vor Biopharma, Inc., an Independent Non-Executive Director at NewAmsterdam Pharma Co. NV, an Independent Director at enGene Therapeutics, Inc. and a General Partner at Forbion Capital Partners Management Holding BV.
He is on the Board of Directors at Vor Biopharma, Inc., NewAmsterdam Pharma Co. NV, enGene Therapeutics, Inc., Beacon Therapeutics Ltd., Navigator Medicines, Inc., VectorY BV and Verdiva Bio, Inc. Mr. Joustra was previously employed as an Independent Director by VectivBio Holding AG, a Non-Executive Director by Gyroscope Therapeutics Holdings Plc, a Non-Independent Director by Forbion European Acquisition Corp., and an Executive Director-Life Sciences Franchise by Kempen & Co. USA, Inc. He also served on the board at VectivBio AG, Aiolos Bio, Inc. and Gyroscope Therapeutics Ltd. He received his undergraduate degree from the University of Nebraska, an undergraduate degree from the University of Groningen and a graduate degree from the University of Groningen.